Media

Media Inquiries

Ghopkins@OncoSec.com

858-210-7334

Press Releases

OncoSec Board Rejects Alpha Holdings “Proposal” and Announces New Special Meeting Date

January 16, 2020

OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms – ISS and Glass Lewis – Have Recommended That OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction on the WHITE Proxy Card

January 06, 2020

Institutional Shareholder Services Inc. ("ISS") Recommends OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction

December 26, 2019

VIEW ALL PRESS RELEASES

Video Feed

3D MOA Animation video

IAD Reel

Tumor Immunogenicity

IAD Robert Andtbacka, M.D.

TAVO Demonstration with Dr Algazi

IAD Robert H. Pierce, M.D.

Social Media

Twitter Feed

OncoSec Medical 3 days ago

Fran learned about #TAVO™, an investigational therapy, from her oncologist when she was at one of her lowest points in her fight against #metastatic #melanoma. Learn more about her experience: http...

OncoSec Medical 5 days ago

Three years ago, Sharon was diagnosed with #melanoma. After undergoing a cycle of treatments that failed to stop her #cancer from spreading, Sharon was introduced to #TAVO™, an investigational thera...

OncoSec Medical 1 week ago

When Julie was diagnosed with #TNBC, she quickly learned that it was the most aggressive type of #breastcancer. Today, she shares her experience using the investigational therapy, #TAVO™, and a stor...

OncoSec Medical 2 weeks ago

Missed the recent conversation on the latest developments on triple negative #breastcancer hosted by @TNBCFoundation during #SABCS19? View the recorded Q&A on #TNBC with Dr. Melinda Telli, Ricki F...